Russell Microcap Index

AppTech Payments Corp. Reports Second Quarter 2023 Results

Retrieved on: 
Monday, August 14, 2023
Partnership, Russell Microcap Index, Bank statement, Mobile payment, Fintech, License, Visa, Silicon, Russell, Mastercard, SMS, Cryptocurrency, Mobile phone, Broadnet Holdings BV

CARLSBAD, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), an innovative Fintech company powering seamless commerce between businesses and consumers, today announced results for its second quarter ended June 30, 2023.

Key Points: 
  • CARLSBAD, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech”) (NASDAQ: APCX), an innovative Fintech company powering seamless commerce between businesses and consumers, today announced results for its second quarter ended June 30, 2023.
  • Revenue was approximately $134 thousand for the three months ended June 30, 2023, up 9% compared to $123 thousand for the three months ended June 30, 2022.
  • Revenue was approximately $223 thousand for the six months ended June 30, 2023, compared to $227 thousand for the prior-year period.
  • Luke D’Angelo, Chief Executive Officer of AppTech, commented: “In the second quarter, we continued to leverage our powerful and differentiated Fintech platform, while the value of our patent portfolio is increasingly being recognized by the market.

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 3, 2023
Vaccine, Priority review, Russell Microcap Index, Influenza, Biotechnology, Food, New Drug Application, Food and Drug Administration, H3N2, Fast Track, Research, CD73, Tavarua, CDTX, Janssen Pharmaceuticals, DFC, Russell, Standard of care, Patient, SAN, Johnson & Johnson, FDA, Therapy, IND, Safety, Pharmaceutical industry, Cryptocurrency, Security (finance), Janssen, Melinta Therapeutics

SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases, today reported financial results for the second quarter ended June 30, 2023 and provided an update on its corporate activities and product pipeline.

Key Points: 
  • SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases, today reported financial results for the second quarter ended June 30, 2023 and provided an update on its corporate activities and product pipeline.
  • “This quarter we made important progress in the advancement of our Cloudbreak® drug-Fc conjugate (DFC) platform,” said Jeffrey Stein, Ph.D., president and chief executive officer of Cidara.
  • Final results of the Phase 2a study are expected later in 2023.
  • However, Janssen has not informed Cidara of any intention to terminate the collaboration agreement between the two parties.

180 Degree Capital Corp. Reports $6.22 Preliminary Net Asset Value Per Share, -1.6% YTD, and Liquid Public Securities and Cash of 87% of Net Assets, as of June 30, 2023

Retrieved on: 
Thursday, July 20, 2023
Russell Microcap Index, SCOR, IVAC, Potbelly Sandwich Shop, Weakness, NAV, Intevac, Comscore, TURN, Greenbriar Capital Corp, Rare-earth element

MONTCLAIR, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported preliminary results as of June 30, 2023.

Key Points: 
  • MONTCLAIR, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported preliminary results as of June 30, 2023.
  • “While we are frustrated with our performance in Q2 2023, we used the quarter to position TURN to benefit should certain catalysts of our holdings occur down the road.
  • Our current belief is that some of these catalysts could materialize over the ensuing months.
  • Management continues to believe that TURN’s stock does not reflect the appropriate value of the company and its holdings.

LiveOne Joins Russell Microcap® Index

Retrieved on: 
Wednesday, June 28, 2023
Russell Microcap Index, Growth, Music, FTSE Russell, Russell, LiveOne, LVO, Cryptocurrency

Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.

Key Points: 
  • Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • Russell indexes are part of FTSE Russell, a leading global index provider.
  • For more information on the Russell Microcap® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website .

GlycoMimetics Announces Its Addition to the Russell Microcap® Index  

Retrieved on: 
Monday, June 26, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Russell Microcap Index, Inflammation, Growth, FTSE Russell, Russell, Cancer

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.

Key Points: 
  • Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • Russell indexes are part of FTSE Russell, a leading global index provider.
  • For more information on the Russell Microcap Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website .

Castellum, Inc. Formally Joins Russell Microcap Index; Comments on Recent Stock Trading Volume

Retrieved on: 
Monday, June 26, 2023
Russell Microcap Index, CTM, Form 10-Q, Risk, Second Continental Congress, NYSE American, Congress, Acquisition, Russell, Annual report, OTC, Security (finance), Federation, Castellum

“Joining the Russell Microcap Index is a key milestone for Castellum ,” said Mark Fuller , President, and Chief Executive Officer of Castellum.

Key Points: 
  • “Joining the Russell Microcap Index is a key milestone for Castellum ,” said Mark Fuller , President, and Chief Executive Officer of Castellum.
  • The next step for us would be to qualify for the Russell 2000 which requires that we continue to grow the Company both organically and through acquisition.
  • “Friday’s activity represents record trading volume for Castellum and helps provide our stockholders with greater liquidity for their holdings.
  • With about 14 million shares in our public float, Friday’s trading represented over 70% of our public float.

Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes

Retrieved on: 
Thursday, June 22, 2023
HBIO, FTSE Russell, Green, Russell, Growth, Russell Microcap Index, Harvard Bioscience, Safety, Cryptocurrency

HOLLISTON, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 3000 Indexes, according to preliminary membership information posted to the FTSE Russell website.

Key Points: 
  • HOLLISTON, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 3000 Indexes, according to preliminary membership information posted to the FTSE Russell website.
  • Jim Green, Harvard Bioscience Chairman and CEO said, “We are pleased that Harvard Bioscience is being added to the Russell 2000 and 3000 Indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • For more information on the Russell indexes and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website .

Daktronics, Inc. set to rejoin Russell 3000® Index

Retrieved on: 
Tuesday, June 20, 2023
Growth, FTSE Russell, Russell Microcap Index, Daktronics, Russell, Cryptocurrency

Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization, including both the Russell 3000 and Russell Microcap Indexes.

Key Points: 
  • Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization, including both the Russell 3000 and Russell Microcap Indexes.
  • Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 3000 Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes.
  • Reece Kurtenbach, chairman, president and chief executive officer, noted, “We are pleased to rejoin the Russell 3000 Index.
  • We believe the inclusion will provide greater visibility and reach to investment managers and institutional investors, providing further exposure to our strategies and results to these investors.”
    For more information on the Russell 3000® Index and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.

Galecto Set to Join Russell Microcap® Index

Retrieved on: 
Tuesday, June 20, 2023
Russell Microcap Index, FTSE Russell, Cancer, Russell Indexes, Fibrosis, Biology, Growth, IPF, Idiopathic pulmonary fibrosis, Cryptocurrency, Galecto Biotech

Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.

Key Points: 
  • Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes.
  • FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
  • “We are pleased to be included in the Russell Microcap Index,” said Hans Schambye, M.D., Ph.D., President and Chief Executive Officer of Galecto.
  • For more information on the Russell Indexes and the Russell U.S. Indexes reconstitution, please visit the FTSE Russell website .

NeoVolta, Solar Battery Manufacturer, Slated to Join Russell Microcap® Index

Retrieved on: 
Tuesday, June 13, 2023
Russell Microcap Index, Growth, FTSE Russell, Cryptocurrency

POWAY, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- NeoVolta (NASDAQ: NEOV), a solar battery manufacturer and developer of smart residential energy storage solutions, will join the Russell Microcap ® Index following the 2023 Russell indexes annual reconstitution, which takes effect once the U.S. market opens on June 26, 2023.

Key Points: 
  • POWAY, Calif., June 13, 2023 (GLOBE NEWSWIRE) -- NeoVolta (NASDAQ: NEOV), a solar battery manufacturer and developer of smart residential energy storage solutions, will join the Russell Microcap ® Index following the 2023 Russell indexes annual reconstitution, which takes effect once the U.S. market opens on June 26, 2023.
  • Membership in the Russell Microcap® Index, which is a one-year term, allows for automatic inclusion in relevant growth and value-style indexes.
  • Investment managers and institutional investors heavily rely on Russell indexes as benchmarks for their investment strategies.
  • “We’re honored to join the Russell Microcap® Index this year, one of the most esteemed performance benchmarks for emerging U.S. companies,”  says Brent Willson, CEO of NeoVolta .